A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia (Q40287113)
Jump to navigation
Jump to search
scientific article published on 16 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia |
scientific article published on 16 September 2006 |
Statements
1 reference
A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia (English)
1 reference
Gonzalo Gomez-Abuin
1 reference
Eric Winquist
1 reference
Walter M Stadler
1 reference
Greg Pond
1 reference
Pamela Degendorfer
1 reference
John Wright
1 reference
Malcolm J Moore
1 reference
16 September 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference